Ardsley Advisory Partners’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-200,000
Closed -$2.38M 145
2024
Q4
$2.38M Sell
200,000
-200,000
-50% -$3.41M 0.38% 84
2024
Q3
$11.1M Hold
400,000
1.82% 12
2024
Q2
$9.54M Buy
+400,000
New +$9.39M 1.4% 18
2024
Q1
Sell
-400,000
Closed -$6.31M 132
2023
Q4
$6.31M Sell
400,000
-450,000
-53% -$4.65M 0.97% 28
2023
Q3
$7.31M Sell
850,000
-501,000
-37% -$3.56M 1.63% 17
2023
Q2
$10.7M Buy
+1,351,000
New +$9.4M 1.8% 12
2023
Q1
Sell
-103,000
Closed -$1.21M 107
2022
Q4
$1.21M Buy
+103,000
New +$1.18M 0.25% 65

Other funds holding ASPN

Ardsley Advisory Partners's ASPN Position: Q1 2025 in Review

Ardsley Advisory Partners sold out of Aspen Aerogels (ASPN) in Q1 2025, closing a stake of 261,100 shares — an estimated $3.1M sold.

Ardsley Advisory Partners first reported a position in ASPN in Q2 2021 and held it in 11 quarters. The position peaked at $16.5M in Q4 2023. 221 funds tracked by Wall St. Rank hold ASPN as of Q1 2025.

  • Ardsley Advisory Partners reported no remaining Aspen Aerogels position as of Q1 2025 after selling out during the quarter.
  • Ardsley Advisory Partners sold 261,100 Aspen Aerogels shares in Q1 2025, an estimated $3.1M.
  • Ardsley Advisory Partners first reported a position in Aspen Aerogels in Q2 2021 and held it in 11 quarters.
  • Ardsley Advisory Partners's Aspen Aerogels position peaked at $16.5M in Q4 2023.
  • 221 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2025.

Based on Ardsley Advisory Partners's 13F filing for Q1 2025, filed 15 May 2025.